nicotine has been researched along with nicotine imine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Obach, RS; Van Vunakis, H | 1 |
Gorrod, JW; Hibberd, AR | 1 |
Berkman, CE; Cashman, JR; Park, SB; Wrighton, SA | 1 |
Obach, RS | 1 |
Cooksy, A; Kovacic, P | 1 |
Murphy, SE; Retzlaff, C; von Weymarn, LB | 1 |
Bloom, AJ; Kharasch, ED; Wang, PF | 1 |
7 other study(ies) available for nicotine and nicotine imine
Article | Year |
---|---|
Nicotinamide adenine dinucleotide (NAD)-dependent oxidation of nicotine-delta 1'(5')-iminium ion to cotinine by rabbit liver microsomes.
Topics: Aldehyde Oxidase; Aldehyde Oxidoreductases; Animals; Arsenic; Arsenites; Cotinine; Microsomes, Liver; NAD; Nicotine; Oxidation-Reduction; Oxidoreductases; Pyrrolidinones; Rabbits; Vitamin K; Water | 1990 |
Nicotine delta 1 "(5)' iminium ion: a reactive intermediate in nicotine metabolism.
Topics: Animals; Biotransformation; Cotinine; Cytosol; Glutathione; Guinea Pigs; Liver; Nicotine; Nitriles; Rabbits | 1981 |
In vitro-in vivo correlations of human (S)-nicotine metabolism.
Topics: Adult; Aldehyde Oxidase; Aldehyde Oxidoreductases; Barbiturates; Biotransformation; Cotinine; Cyclic N-Oxides; Female; Humans; Kinetics; Male; Microsomes, Liver; Middle Aged; Nicotine; Stereoisomerism | 1995 |
Potent inhibition of human liver aldehyde oxidase by raloxifene.
Topics: Aldehyde Oxidase; Benzaldehydes; Enzyme Inhibitors; Humans; In Vitro Techniques; Kinetics; Liver; Nicotine; Oxidation-Reduction; Phthalazines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Xanthine Oxidase | 2004 |
Iminium metabolite mechanism for nicotine toxicity and addiction: Oxidative stress and electron transfer.
Topics: Animals; Computer Simulation; Electron Transport; Humans; Models, Biological; Nicotine; Oxidative Stress; Reactive Oxygen Species; Tobacco Use Disorder | 2005 |
CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine Δ5'(1')iminium ion.
Topics: Aryl Hydrocarbon Hydroxylases; Catalysis; Chromatography, High Pressure Liquid; Cotinine; Coumarins; Cytochrome P-450 CYP2A6; Enzyme Inhibitors; Humans; Kinetics; NADP; Nicotiana; Nicotine; Nicotinic Agonists; Oxidation-Reduction; Tritium | 2012 |
Nicotine oxidation by genetic variants of CYP2B6 and in human brain microsomes.
Topics: Aged; Aged, 80 and over; Brain; Cytochrome P-450 CYP2B6; Female; Humans; Ketamine; Male; Methadone; Microsomes; Middle Aged; Nicotine; Oxidation-Reduction; Polymorphism, Single Nucleotide; Recombinant Proteins; Stereoisomerism; Tobacco Use Disorder | 2019 |